KACY SCARPA: Open Payments
NPI 1508405259 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,092 in 185 payments from 22 companies in 2025. Trend: 2023 $1,323 · 2024 $2,168 · 2025 $3,092
Food & beverage: $2,998Education: $94
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 44 | $696 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 38 | $592 |
| Madrigal Pharmaceuticals | 7 | $285 |
| ABBVIE INC. | 21 | $247 |
| Lilly USA, LLC | 16 | $243 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $181 |
| PFIZER INC. | 14 | $156 |
| Exact Sciences Corporation | 8 | $129 |
| Abbott Laboratories | 4 | $91 |
| Regeneron Healthcare Solutions, Inc. | 3 | $64 |
Products named: TREMFYA, XIFAXAN, REZDIFFRA, ENTYVIO, VELSIPITY, RINVOQ, RELISTOR, OMVOH.
Industry payments across NY — which companies pay providers there.
